AllPeptides.eu - Advanced Peptide Research

    ⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer

    Nasal Spray
    Stronger intranasal relevance

    Oxytocin (Nasal Spray)

    Intranasal (nasal spray)1× daily (typical in studies)

    Oxytocin as a nasal spray is extensively studied for social behavior, trust, and psychiatric disorders.

    Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16

    Mechanism of Action

    Oxytocin is a 9-amino acid neuropeptide investigated for its role in social bonding, trust, and emotional regulation. Nasal administration is studied as a potential way to increase central levels, although the exact mechanism of CNS access remains under investigation.

    Overview

    • Nasal administration — widely studied
    • Clinical doses: 24–40 IU per application
    • Hundreds of published studies
    • Commercial formulations available in some countries

    Intranasal Delivery — Research Data

    • Intranasal Oxytocin has been extensively studied in hundreds of clinical trials.
    • Approved nasal spray formulations exist (Syntocinon Spray) in some countries.
    • Nasal bioavailability is widely studied, although the exact degree of CNS access remains under active investigation.

    Stronger intranasal relevance

    Clinical studies or approved formulations exist for intranasal delivery.

    Detailed Protocol Data

    Dosing Table — Oxytocin Nasal Spray

    Educational only
    PeriodDoseNotes
    Typical research dose24 IU6 sprays (4 IU/spray)
    Higher dose (studies)40 IU10 sprays (4 IU/spray)

    Doses are based on published clinical studies. No self-administration guidance is provided.

    Formulation Notes

    No self-preparation instructions provided

    • Commercial formulations are available as ready-to-use nasal sprays.
    • Self-preparation of nasal spray from injectable oxytocin is not recommended.

    Storage After Opening

    • Refrigerator (2–8°C).
    • Use within 28 days after opening.

    Dosing Protocol

    • 24–40 IU, 1× daily or before experimental conditions.

    Storage Instructions

    • Refrigerator (2–8°C).
    • After first opening, use within 28 days.

    Important Notes

    • Intranasal oxytocin is not FDA-approved for psychiatric indications.
    • Research use only — study results are mixed.
    • No self-preparation instructions are provided.
    Clinical Analysis & Safety

    Benefits & Side Effects

    Potential Benefits

    • Potential enhancement of social cognition (research data)
    • Investigated in autism and social phobia
    • Non-invasive administration

    Potential Side Effects

    • Mild nasal irritation
    • Rarely: headache, rhinorrhea
    • Potential effects on hormonal balance with prolonged use

    References

    1. Effects of intranasal Oxytocin on social cognition: a meta-analysis — Meta-analysis of the effects of intranasal oxytocin on social cognition
      Source →
    2. Oxytocin nasal spray in autism spectrum disorders — Clinical trial in children with autism
      Source →

    Intranasal Peptide Delivery: Complete Guide

    Bioavailability, absorption factors, comparison with injectables, and limitations of nasal delivery.

    Research Limitations

    The data on this page is strictly educational. No self-preparation or self-administration instructions are provided.

    Research Sources & Verified Data
    …
    Clinical Trials
    …
    PubMed Studies
    Approved
    FDA Status
    3
    Regulatory Approvals
    Verified across ClinicalTrials.gov, PubMed & FDA

    External Sources & Regulatory Status

    Regulatory Approvals

    🇺🇸
    FDA
    Approved

    Pitocin® · Labour / Obstetrics (1980)

    🇪🇺
    EMA
    Approved

    Syntocinon® · Labour

    🇯🇵
    PMDA
    Approved

    Labour

    Approved worldwide

    No official regulatory source available yet — research peptide.

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Summary:
    3 Approvals
    0 PubMed
    0 Clinical Studies
    Educational contentRegularly reviewed & maintainedEvidence-based review

    Important Disclaimer

    The content of this website is provided exclusively for informational and educational purposes within the context of research literature.

    Read the full Disclaimer →

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu